Shaheduzzaman et al. [21] demonstrated that LTF mRNA expression in tumour cells revealed a marked downregulation of LTF, with significant associations with a decreased prostate-specific antigen (PSA) recurrence-free survival of patients with CaP. This evidence concerns the gene KLK3 and neoplasm.